Brief: Bio Path Received Deficiency Letter From Nasdaq Notifying Co Is Not In Compliance With Minimum Stockholders' Equity Requirement
13/03/2024 21:52
March 13 (Reuters) - Bio Path Holdings Inc BPTH.O :
* BIO PATH HOLDINGS : ON MAR 12, RECEIVED DEFICIENCY LETTER
FROM
NASDAQ NOTIFYING CO IS NOT IN COMPLIANCE WITH MINIMUM
STOCKHOLDERS' EQUITY REQUIREMENT
Source text for Eikon: ID:n0001558370-24-003118
Further company coverage: BPTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia